Financial Results for March 31, 2014 (Audited)
Bliss GVS Pharma Ltd has informed BSE about the Financial Results for the period ended March 31, 2014.28-05-2014
Financial Results for March 31, 2014 (Audited)
Bliss GVS Pharma Ltd has informed BSE about the Financial Results for the period ended March 31, 2014.Board recommends Final Dividend
Bliss GVS Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 26, 2014, inter alia, has recommended a Final Dividend of 50% i.e. Rs. 0.50/- per Equity Share for the year ended March 31, 2014.Board to consider Dividend
Bliss GVS Pharma Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 26, 2014, inter alia, to consider:1. The Audited Financial Results of the company for the quarter and year ended March 31, 2014.2. And dividend if any.Shareholding Pattern for March 31, 2014
Bliss GVS Pharma Ltd has informed BSE about the Shareholding Pattern for the Quarter ended March 31, 2014.Appointment of Company Secretary
Bliss GVS Pharma Ltd has informed BSE that Mrs. Sushma Yadav is appointed as a Company Secretary of the Company on account of resignation of Mr. Amarendra Mohapatra.Financial Results & Limited Review for Dec 31, 2013
Bliss GVS Pharma Ltd has informed BSE that about the Financial Results & a copy of the Limited Review Report for the period ended December 31, 2013.Limited Review for Sept 30, 2013
Bliss GVS Pharma Ltd has submitted to BSE a Copy of the Limited Review Report for the period ended Sept 30, 2013.Financial Results for Sept 30, 2013
Bliss GVS Pharma Ltd has informed BSE about the Financial Results for the period ended Sept 30, 2013.Clarification - Sale of stake of M/s Bliss GVS Pharma Ltd of Pfizer Ltd
Bliss GVS Pharma Ltd has informed BSE that the Company has came to know from shareholders and from social media sites that Pfizer is taking with the management to acquire stake in the Company. The Company has deny this news and the Company is not in any discussion with M/s Pfizer Ltd or its management or not given any mandate for discussion of sale of any of its units or stake of the Company. This news is purely based on rumours.